NCT01148524 - Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10 | Biotech Hunter

Enrollment

817

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Meningococcal DiseaseMeningococcal Meningitis

Interventions

BIOLOGICAL

No Vaccine

BIOLOGICAL

rMenB+OMV-NZ

Subjects who had received either rMenB+OMV-NZ or placebo at study month 6 in V72P10 study had a blood sample drawn for serological analyses at 18 months later (-1/+3 months).

Trial Locations (6)

Unknown

Centro de Salud Lo Barnechea, Santiago

Centro para vacunas en desarrollo. Hospital de Niños Roberto del Río, Santiago

Escuela de Medicina de la Universidad de Valparaíso, Santiago

Hospital Luis Calvo Mackenna, Santiago

Liceo Jose Victorino Lastarria, Santiago

Universidad de Chile. Facultad de Medicina, Santiago